Table 1.
Characteristic | Parameter | IMRT (N = 334) | PBT (N = 146) | P value |
---|---|---|---|---|
Age (years) | Mean, Median (Minimum-Maximum) | 59.0, 60 (26 – 82) | 61.3, 64 (26 – 76) | 0.018 |
PTV (cc) | Mean, Median (Minimum-Maximum) | 707, 653 (112 – 2554) | 552, 506 (174 – 1727) | <0.001 |
Gender, n (%) | Female | 40 (12) | 15 (10) | 0.59 |
Male | 294 (88) | 131 (90) | ||
Stage, n (%) | I | 1 (0) | 4 (3) | 0.09 |
IIA | 115 (34) | 46 (32) | ||
IIB | 10 (3) | 8 (5) | ||
III | 196 (59) | 82 (56) | ||
IVA | 12 (4) | 6 (4) | ||
KPS, n (%) | 70 | 13 (4) | 2 (1) | 0.25 |
80–100 | 321 (96) | 144 (99) | ||
Tumor location, n (%) | Upper-Middle | 19 (6) | 6 (4) | 0.47 |
Lower | 315 (94) | 140 (96) | ||
Induction chemotherapy, n (%) | No | 205 (61) | 96 (66) | 0.36 |
Yes | 129 (39) | 50 (34) | ||
Histology, n (%) | Adenocarcinoma | 313 (94) | 140 (96) | 0.14 |
SCC | 21 (6) | 5 (3) | ||
Other | 0 | 1 (1) |
Abbreviations: IMRT = intensity-modulated radiation therapy, PBT = proton beam therapy, PTV = planning target volume, KPS = Karnofsky performance status, SCC = Squamous cell carcinoma, RT = radiation therapy.